Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (2409)	12/28/2000 4:44:30 AM
From: Londo	Read Replies (1) \| Respond to of 52153

Well, I'll confess that the research would be worth more providing that we all know that there was the cash around to continue it.. Wasn't the fundamental criteria "a biotech company should have at least 3 years worth of cash on hand" for a particular reason? As for AXPH.. nice move for them to dump PPGx for some cash - they can use it as well.. at least they've got something in Phase II... I've been looking at this one for no particular reason for awhile now, but I haven't seen anything that has made the jump from 'watch list' to 'investment candidate'. That conference certainly would be interesting to attend - looks to be as much an educational experience about the technology those companies are working on in addition to hyping their stocks.. As for SGMO, it looks like that the dart just hit the right section of the newspaper.. although the fact that insiders were dumping at 20 bucks doesn't give me much hope for that stock.. And yeah, Londo is from the show B5... I chose the name because sometimes my hair looks like his when I get up in the morning.